scholarly journals Single-cell heterogeneity in Sézary syndrome

2018 ◽  
Vol 2 (16) ◽  
pp. 2115-2126 ◽  
Author(s):  
Terkild Brink Buus ◽  
Andreas Willerslev-Olsen ◽  
Simon Fredholm ◽  
Edda Blümel ◽  
Claudia Nastasi ◽  
...  

Key Points Individual patients with Sézary syndrome contain several distinct malignant subpopulations and show marked single-cell heterogeneity. Malignant subpopulations exhibit differences in their sensitivity to treatment warranting precision therapy.

2021 ◽  
Vol 141 (5) ◽  
pp. S12
Author(s):  
N. Borcherding ◽  
N. Henderson ◽  
L. Ortolan ◽  
V. Liu ◽  
B. Link ◽  
...  

Blood ◽  
2015 ◽  
Vol 125 (1) ◽  
pp. 71-81 ◽  
Author(s):  
Charlotte F. M. Hughes ◽  
Amit Khot ◽  
Christopher McCormack ◽  
Stephen Lade ◽  
David A. Westerman ◽  
...  

Key Points Chemotherapy results in a short median time to next treatment in patients with mycosis fungoides/Sézary syndrome. α-interferon achieves a superior time to next treatment compared with chemotherapy, regardless of stage.


Blood ◽  
2017 ◽  
Vol 129 (17) ◽  
pp. 2384-2394 ◽  
Author(s):  
Rebecca Warfvinge ◽  
Linda Geironson ◽  
Mikael N. E. Sommarin ◽  
Stefan Lang ◽  
Christine Karlsson ◽  
...  

Key Points Single-cell gene expression analysis reveals CML stem cell heterogeneity and changes imposed by TKI therapy. A subpopulation with primitive, quiescent signature and increased survival to therapy can be high-purity captured as CD45RA−cKIT−CD26+.


2012 ◽  
Vol 8 (8) ◽  
pp. 699-701 ◽  
Author(s):  
Enrico Scala ◽  
Maria Grazia Narducci ◽  
Giandomenico Russo

Blood ◽  
2016 ◽  
Vol 127 (26) ◽  
pp. 3387-3397 ◽  
Author(s):  
Wesley J. Woollard ◽  
Venu Pullabhatla ◽  
Anna Lorenc ◽  
Varsha M. Patel ◽  
Rosie M. Butler ◽  
...  

Key Points Aberrations in genome maintenance and DNA repair genes including POT1 occur at a high frequency in Sézary syndrome. Candidate driver genes and affected pathways in Sézary syndrome show extensive heterogeneity but overlap with other mature T-cell lymphomas.


Blood ◽  
2021 ◽  
Vol 138 (16) ◽  
pp. 1384-1386
Author(s):  
Audrey Gros ◽  
Jean-Philippe Merlio

Blood ◽  
2013 ◽  
Vol 122 (10) ◽  
pp. 1802-1812 ◽  
Author(s):  
Shen Dong ◽  
Sylvie Maiella ◽  
Aliénor Xhaard ◽  
Yuanyu Pang ◽  
Lynn Wenandy ◽  
...  

Key Points Single-cell heterogeneity, rather than lineage reprogramming, explains the remarkable complexity and functional diversity of human Tregs. Altered homeostasis of Treg subpopulations in patients developing acute graft-versus-host disease.


Blood ◽  
2013 ◽  
Vol 122 (20) ◽  
pp. 3511-3520 ◽  
Author(s):  
Cristina Cristofoletti ◽  
Maria Cristina Picchio ◽  
Cristina Lazzeri ◽  
Valeria Tocco ◽  
Elena Pagani ◽  
...  

Key Points PTEN is downregulated in Sézary syndrome by different mechanisms, mostly by gene deletions and microRNAs. PTEN deficiency activates AKT in skin resident but not circulating Sezary cells.


Blood ◽  
2015 ◽  
Vol 125 (12) ◽  
pp. 1883-1889 ◽  
Author(s):  
Madeleine Duvic ◽  
Lauren C. Pinter-Brown ◽  
Francine M. Foss ◽  
Lubomir Sokol ◽  
Jeffrey L. Jorgensen ◽  
...  

Key Points Mogamulizumab was well-tolerated in 41 patients with previously treated mycosis fungoides or Sézary syndrome. Durable responses observed with a global overall response rate of 36.8%; patients with Sézary syndrome had a response rate of 47.1%.


1970 ◽  
Vol 101 (2) ◽  
pp. 244-246 ◽  
Author(s):  
H. H. Roenigk

Sign in / Sign up

Export Citation Format

Share Document